Views:0 Author:Site Editor Publish Time: 2021-01-04 Origin:Site
Phosphenytoin is used to prevent and treat seizures. Phosphoenytoin sodium encapsulated with betadex sulfobutyl ether sodium (SBEBCD) can maximize the safety of administration and improve the solubility, stability and bioavailability of the active pharmaceutical ingredient (API). SESQUIENT™ (fosphenytoin sodium for injection) is the only FDA-approved room-temperature stable formulation of fosphenytoin sodium. It is FDA approved for adult and pediatric use in the U.S. to treat generalized tonic-clonic status epilepticus, the prevention and treatment of seizures occurring during neurosurgery and for substitution short-term use in place of oral phenytoin, when oral phenytoin administration is not possible.
The betadex sulfobutyl ether sodium (SBEBCD) (DMF record number 030167) produced by Shandong Binzhou Zhiyuan Biotechnology Co., Ltd. has been jointly declared with pharmaceutical companies and will be activated soon.
Please contact with us if you want to get more information.
+86 531 88916568